🇵🇱 Poland Country × Condition
stereotactic body radiation therapy sbrt Clinical Trials in Poland
Active clinical trials for stereotactic body radiation therapy sbrt with research sites in Poland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇵🇱 Poland
Active Trials in Poland (2)
NCT07426094 Phase 2, Phase 3
Recruiting
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
Enrollment
600 pts
Country
🇵🇱 Poland
Affidea Nu-med Center of Oncologica...
View Trial → NCT07426055 Phase 2, Phase 3
Recruiting
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
Enrollment
1,000 pts
Country
🇵🇱 Poland
Affidea Nu-med Center of Oncologica...
View Trial → Frequently Asked Questions
How many stereotactic body radiation therapy sbrt clinical trials are active in Poland?
There are currently 2 active clinical trials for stereotactic body radiation therapy sbrt with sites in Poland, of which 2 are actively recruiting patients.
How can I join a stereotactic body radiation therapy sbrt clinical trial in Poland?
To join a stereotactic body radiation therapy sbrt clinical trial in Poland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Poland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are stereotactic body radiation therapy sbrt trials in Poland?
Active stereotactic body radiation therapy sbrt trials in Poland span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology